new research shows combination two drugs given surgery substantially reduces death rate patients advanced colon cancer national cancer institute announced monday this major advance dr samuel broder director cancer institute said press conference the results suggest might able reduce death rate much onethird federal health officials said findings compelling researchers decided discontinue comparison portions studies patients observation drug therapy urge patients consider taking combination drug treatment doctors alerted also broder said cancer institute alerted 35000 physicians surgeons major institutions treating cancer we encouraged said joanne schellenbach spokeswoman american cancer society there definitely need armaments war advanced colon cancer in 1989 estimated 107000 new cases colon cancer expected excluding common skin cancers combined incidence colon rectum cancer estimated total 151000 new cases year second lung cancer country about 53500 colon cancer deaths expected year the studies used levamisole drug available country veterinarians treatment intestinal worms 5fluorouracil 5fu wellknown anticancer drug 30 years the drugs started three five weeks surgery given one year colon cancer patients whose cancer spread adjacent lymph nodes advanced stage colon cancer known dukes c about 21000 people diagnosed year dukes c colon cancer in one study 49 patients alive five years therapy contrasted 37 received treatment surgery scientists said in study 408 patients dukes b earlier stage dukes c colon cancer randomly chosen receive either observation surgery levamisole alone combination drug therapy compared postsurgical observationonly group patients received levamisole 5fu significantly fewer tumor recurrences five years 55 versus 41 in cases recur using drug combination longer delays recurrence 23 months versus 14 months results combination therapy dukes b colon cancer inconclusive researchers said some patients not helped also treatment benefit patients whose cancer spread beyond lymph nodes said the study sponsored cancer institute conducted north central cancer treatment group direction dr charles g moertel cancer specialist mayo clinic rochester minn the findings reported current journal clinical oncology we feel come great confidence tell treatment value said moertel press conference i feel patient highrisk colon cancer really getting short shrift offered treatment opportunity said a second larger study confirms findings expected published shortly provides data suggest onethird reduction cancer death rate 3 12 years surgery researchers said this study also sponsored cancer institute used 1296 patients 1984 1987 like earlier study showed two drugs taken combination reduced recurrence rates delayed onset tumor relapse improved diseasefree overall survival dukes c patients scientists said researchers said levamisole used alone showed little benefit combination therapy yet shown value stages colon cancer treatment rectum cancer 5fu already shown benefit patients digestive system cancers levamisole used past 20 years treatment intestinal worms humans animals although approved country use animals last may request cancer institute food drug administration approved expanded use levamisole treating colon cancer mechanism known treatment ind investigational new drug the designation allows drug developers release potentially promising drug desperately ill patients approved research continues the drug made paul janssen co belgium available us cancer patients free national cancer institute fda formally approves use treatment colon cancer 5fu developed hoffmannlaroche inc nutley nj